Profile | GDS4284 / 222286_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1145.13 | 76 |
GSM687648 | Patient 402 control | 1077.72 | 75 |
GSM687653 | Patient 403 control | 975.591 | 74 |
GSM687658 | Patient 404 control | 1240.87 | 77 |
GSM687663 | Patient 411 control | 987.363 | 74 |
GSM687668 | Patient 422 control | 1194.32 | 76 |
GSM687673 | Patient 424 control | 1053.92 | 75 |
GSM687678 | Patient 425 control | 1152.71 | 75 |
GSM687683 | Patient 427 control | 1698.25 | 81 |
GSM687688 | Patient 428 control | 1151.05 | 76 |
GSM687695 | Patient 441 control | 696.177 | 68 |
GSM687699 | Patient 443 control | 1478.35 | 80 |
GSM687704 | Patient 444 control | 1053.37 | 75 |
GSM687707 | Patient 448 control | 1566.3 | 81 |
GSM687712 | Patient 449 control | 1597.47 | 81 |
GSM687719 | Patient 450 control | 871.213 | 71 |
GSM687724 | Patient 451 control | 934.491 | 73 |
GSM687728 | Patient 452 control | 1054.33 | 75 |
GSM687646 | Patient 401 treated 24h | 1843.62 | 82 |
GSM687649 | Patient 402 treated 24h | 901.54 | 72 |
GSM687665 | Patient 411 treated 24h | 952.041 | 73 |
GSM687651 | Patient 402 treated 4 weeks | 969.991 | 73 |
GSM687667 | Patient 411 treated 4 weeks | 1080.18 | 75 |
GSM687670 | Patient 422 treated 24h | 1255.64 | 77 |
GSM687671 | Patient 422 treated 4 weeks | 1362.78 | 78 |
GSM687654 | Patient 403 treated 24h | 919.701 | 73 |
GSM687675 | Patient 424 treated 24h | 975.285 | 73 |
GSM687685 | Patient 427 treated 24h | 1208.97 | 77 |
GSM687656 | Patient 403 treated 4 weeks | 952.799 | 73 |
GSM687677 | Patient 424 treated 4 weeks | 1188.16 | 76 |
GSM687687 | Patient 427 treated 4 weeks | 1267.48 | 77 |
GSM687692 | Patient 428 treated 4h | 1658.85 | 81 |
GSM687716 | Patient 449 treated 4h | 1053.68 | 75 |
GSM687722 | Patient 450 treated 4h | 883.871 | 72 |
GSM687680 | Patient 425 treated 24h | 1055.83 | 74 |
GSM687690 | Patient 428 treated 24h | 1490.41 | 80 |
GSM687700 | Patient 443 treated 24h | 953.285 | 72 |
GSM687705 | Patient 444 treated 24h | 948.952 | 74 |
GSM687714 | Patient 449 treated 24h | 1439.47 | 80 |
GSM687721 | Patient 450 treated 24h | 624.734 | 66 |
GSM687682 | Patient 425 treated 4 weeks | 912.437 | 73 |
GSM687694 | Patient 428 treated 4 weeks | 1453.43 | 79 |
GSM687702 | Patient 443 treated 4 weeks | 1220.2 | 77 |
GSM687718 | Patient 449 treated 4 weeks | 1424.19 | 79 |
GSM687723 | Patient 450 treated 4 weeks | 913.276 | 73 |
GSM687661 | Patient 404 treated 4h | 1397.45 | 79 |
GSM687710 | Patient 448 treated 4h | 800.277 | 71 |
GSM687726 | Patient 451 treated 4h | 1109.95 | 76 |
GSM687730 | Patient 452 treated 4h | 939.584 | 72 |
GSM687660 | Patient 404 treated 24h | 695.668 | 70 |
GSM687697 | Patient 441 treated 24h | 730.155 | 69 |
GSM687709 | Patient 448 treated 24h | 1122.62 | 76 |
GSM687725 | Patient 451 treated 24h | 740.912 | 69 |
GSM687729 | Patient 452 treated 24h | 528.023 | 65 |
GSM687727 | Patient 451 treated 4 weeks | 1128.21 | 76 |
GSM687731 | Patient 452 treated 4 weeks | 854.267 | 71 |